Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Carbone

Showing results (571-580 of 651) with videos related to

Pageof 66
Sort By:
JTO Clinical and Research Reports|September 30, 2021
Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research AutopsyHui-Zi Chen, Russell Bonneville, Anoosha Paruchuri, et al.
Journal of Extracellular Vesicles|September 12, 2022
An immunogold single extracellular vesicular RNA and protein (<sup>Au</sup> SERP) biochip to predict responses to immunotherapy in non-small cell lung cancer patientsLuong T H Nguyen, Jingjing Zhang, Xilal Y Rima, et al.
Cell Reports|April 14, 2023
Exercise training remodels inguinal white adipose tissue through adaptations in innervation, vascularization, and the extracellular matrixPasquale Nigro, Maria Vamvini, Jiekun Yang, et al.
JAMA Oncology|July 25, 2024
Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase II Nonrandomized Controlled TrialHelen J Ross, David Kozono, Xiaofei F Wang, et al.
Oncoimmunology|February 21, 2025
Evaluating the effect of immune checkpoint inhibitor treatment on chronic obstructive pulmonary disease in lung cancer patientsAnet Greib, Songzhu Zhao, Michelle Ploch, et al.
Nature Communications|July 31, 2021
AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicingGeorgios I Laliotis, Evangelia Chavdoula, Maria D Paraskevopoulou, et al.
Cancer Treatment Reports|July 1, 1976
Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lungJ H Edmonson, S W Lagakos, O S Selawry, et al.
British Journal of Cancer|October 17, 2022
Utility of cell-free DNA from bronchial washing fluid in diagnosis and genomic determination for radiology-suspected pulmonary nodulesXinyu Zhang, Zhuo Yu, Yaping Xu, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
An <i>in vivo</i> "turning model" reveals new RanBP9 interactions in lung macrophagesYasuko Kajimura, Anna Tessari, Arturo Orlacchio, et al.
Nature Communications|June 28, 2022
Retraction Note: AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicingGeorgios I Laliotis, Evangelia Chavdoula, Maria D Paraskevopoulou, et al.
Pageof 66

Showing results (571-580 of 651) with videos related to

Sort By:
Pageof 66
JTO Clinical and Research Reports|September 30, 2021
Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research AutopsyHui-Zi Chen, Russell Bonneville, Anoosha Paruchuri, et al.
Journal of Extracellular Vesicles|September 12, 2022
An immunogold single extracellular vesicular RNA and protein (<sup>Au</sup> SERP) biochip to predict responses to immunotherapy in non-small cell lung cancer patientsLuong T H Nguyen, Jingjing Zhang, Xilal Y Rima, et al.
Cell Reports|April 14, 2023
Exercise training remodels inguinal white adipose tissue through adaptations in innervation, vascularization, and the extracellular matrixPasquale Nigro, Maria Vamvini, Jiekun Yang, et al.
JAMA Oncology|July 25, 2024
Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase II Nonrandomized Controlled TrialHelen J Ross, David Kozono, Xiaofei F Wang, et al.
Oncoimmunology|February 21, 2025
Evaluating the effect of immune checkpoint inhibitor treatment on chronic obstructive pulmonary disease in lung cancer patientsAnet Greib, Songzhu Zhao, Michelle Ploch, et al.
Nature Communications|July 31, 2021
AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicingGeorgios I Laliotis, Evangelia Chavdoula, Maria D Paraskevopoulou, et al.
Cancer Treatment Reports|July 1, 1976
Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lungJ H Edmonson, S W Lagakos, O S Selawry, et al.
British Journal of Cancer|October 17, 2022
Utility of cell-free DNA from bronchial washing fluid in diagnosis and genomic determination for radiology-suspected pulmonary nodulesXinyu Zhang, Zhuo Yu, Yaping Xu, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
An <i>in vivo</i> "turning model" reveals new RanBP9 interactions in lung macrophagesYasuko Kajimura, Anna Tessari, Arturo Orlacchio, et al.
Nature Communications|June 28, 2022
Retraction Note: AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicingGeorgios I Laliotis, Evangelia Chavdoula, Maria D Paraskevopoulou, et al.
Pageof 66